Inhibition of IDO activity by epacadostat (INCB024360

Inhibition of IDO activity by epacadostat (INCB024360) activates tumor infiltrating lymphocytes in a patient-derived 3D ex vivosystem of lung cancer and alleviates stromal immunosuppression

Melanie Mediavilla-Varela Ph.D., Melba Marie Page Ph.D., Jenny Kreahling, Ph.D. Peggy Scherle, Scott Antonia, M.D., Soner Altiok, M.D., Ph.D. Nilogen Oncosystems, Incyte Corporation, H. Lee Moffitt Cancer Center. The Society for Immunotherapy of Cancer (SITC). 11/08/2017 to 11/12/17.  National Harbor, MD, USA.

DOWNLOAD poster